Received Apr 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 95BJ9 | IM / LA |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Y011731 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 3 | X1D141M | IM / RA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 2 | U8274AA | IM / LA |
Catch-up dose was given too soon. IPV dose #2 was administered on 01/07/2025. IPV dose #3 was administered on 04/01/2025. There were no adverse reactions. This vaccine was administered along with Tdap, Hep A and Hep B on 04/01/2025.
None
No
None
None reported
None